Lilly Jumps Most Since 2008 as Data Shock After Pfizer Flop

(Bloomberg) -- Eli Lilly & Co. surged the most since 2008 after a positive study for its drug combination in patients with a type of breast cancer was heralded by analysts as a surprising and trans...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.